Although we did not determine the PTM of HMGB1 in response to LPS and we carried out experiments only in the setting of LPS stimulated macrophages, we provided a valuable clue that the CD11b inhibitor such as Gu-4 might be used as a therapeutic agent for the blockade of HMGB1 active release in sepsis. Here, HMGB1 is linked to Sepsis.